Sorafenib for the treatment of advanced hepatocellular carcinoma with extrahepatic metastasis: a prospective multicenter cohort study
Masahito Nakano(Kurume University), Hajime Aino, Hironori Koga(Kurume University), Takuji Torimura(Omuta hospital), Hiroaki Nagamatsu, Manabu Satani(Kurume University), Shigeo Shimose(Kurume University), Masatoshi Tanaka(Fukushima Medical University), Hideki Iwamoto, Ryoko Kuromatsu(Kurume University), Takashi Niizeki(Kurume University), Nobuyoshi Tajiri(Kurume University), Tomotake Shirono(Kurume University), Shusuke Okamura(Kurume University)
Cited by 65
Related Papers
Therapeutic effects of restricted diet and exercise in obese patients with fatty liver
|Journal of Hepatology|1997|614
Clinical practice guidelines for hepatocellular carcinoma: The Japan Society of Hepatology 2017 (4th JSH‐HCC guidelines) 2019 update
|Hepatology Research|2019|539
Aerobic vs. resistance exercise in non-alcoholic fatty liver disease: A systematic review
|Journal of Hepatology|2016|504
MAFLD identifies patients with significant hepatic fibrosis better than NAFLD
|Liver International|2020|410